French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults, Journal of the International AIDS Society, vol.17, issue.1, 2014. ,
DOI : 10.7448/IAS.17.1.19034
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.), HIV Med, vol.15, pp.1-85, 2014. ,
Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV Infection, PLoS ONE, vol.355, issue.3, p.33948, 2012. ,
DOI : 10.1371/journal.pone.0033948.t002
Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapy, Journal of Antimicrobial Chemotherapy, vol.68, issue.8, pp.1857-61, 2013. ,
DOI : 10.1093/jac/dkt120
Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts, Journal of Antimicrobial Chemotherapy, vol.68, issue.5 ,
DOI : 10.1093/jac/dks533
Rates of HIV???1 Transmission per Coital Act, by Stage of HIV???1 Infection, in Rakai, Uganda, The Journal of Infectious Diseases, vol.191, issue.9, pp.1403-1412, 2005. ,
DOI : 10.1086/429411
Short-course antiretroviral therapy in primary HIV infection, N Engl J Med, vol.368, pp.207-224, 2013. ,
The Setpoint Study (ACTG A5217): Effect of Immediate Versus Deferred Antiretroviral Therapy on Virologic Set Point in Recently HIV-1-Infected Individuals, Journal of Infectious Diseases, vol.205, issue.1, pp.87-96, 2012. ,
DOI : 10.1093/infdis/jir699
Rapid CD4+ Cell Decrease After Transient cART Initiated During Primary HIV Infection (ANRS PRIMO and SEROCO Cohorts), JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.49, issue.3, pp.251-259, 2008. ,
DOI : 10.1097/QAI.0b013e318189a739
Temporary Treatment during Primary HIV Infection Does Not Affect Virologic Response to Subsequent Long-Term Treatment, PLoS ONE, vol.67, issue.(3), p.89639, 2014. ,
DOI : 10.1371/journal.pone.0089639.t001
HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy, Antiviral Therapy, vol.17, issue.6, pp.1001-1010, 2012. ,
DOI : 10.3851/IMP2273
Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion, Archives of Internal Medicine, vol.172, issue.16, pp.1252-1257, 2012. ,
DOI : 10.1001/archinternmed.2012.2719
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study, PLoS Pathogens, vol.22, issue.16, p.1003211, 2013. ,
DOI : 10.1371/journal.ppat.1003211.s007
URL : https://hal.archives-ouvertes.fr/pasteur-01420534
Is Clinical Practice Concordant with the Changes in Guidelines for Antiretroviral Therapy Initiation during Primary and Chronic HIV-1 Infection? The ANRS PRIMO and COPANA Cohorts, PLoS ONE, vol.365, issue.8, p.71473, 2013. ,
DOI : 10.1371/journal.pone.0071473.t003
URL : https://hal.archives-ouvertes.fr/hal-00874822
Increasing HIV-1 Non-B Subtype Primary Infections in Patients in France and Effect of HIV Subtypes on Virological and Immunological Responses to Combined Antiretroviral Therapy, Clinical Infectious Diseases, vol.56, issue.6, pp.880-887, 2013. ,
DOI : 10.1093/cid/cis999
Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV, AIDS, vol.26, issue.6, pp.711-731, 2012. ,
DOI : 10.1097/QAD.0b013e3283519214
Interruption of Antiretroviral Therapy Initiated during Primary HIV-1 Infection: Impact of a Therapeutic Vaccination Strategy Combined with Interleukin (IL)-2 Compared with IL-2 Alone in the ANRS 095 Randomized Study, AIDS Research and Human Retroviruses, vol.23, issue.9, pp.1105-1118, 2007. ,
DOI : 10.1089/aid.2007.0047
Continuous versus intermittent treatment strategies during primary HIV-1 infection, AIDS, vol.26, issue.15, pp.1895-905, 2012. ,
DOI : 10.1097/QAD.0b013e32835844d9
URL : https://hal.archives-ouvertes.fr/hal-00875175
Discordance Between CD4+ T-Lymphocyte Counts and Percentages in HIV-Infected Persons With Liver Fibrosis, Clinical Infectious Diseases, vol.54, issue.12, pp.1806-1819, 2012. ,
DOI : 10.1093/cid/cis294
Immunological recovery and antiretroviral therapy in HIV-1 infection, The Lancet Infectious Diseases, vol.6, issue.5, pp.280-287, 2006. ,
DOI : 10.1016/S1473-3099(06)70463-7
Rates and Determinants of Virologic and Immunological Response to HAART Resumption After Treatment Interruption in HIV-1 Clinical Practice, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.49, issue.5, pp.492-500, 2008. ,
DOI : 10.1097/QAI.0b013e318186ead2
Decline of CD4+ T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individuals, AIDS, vol.25, issue.8, pp.1041-1050, 2011. ,
DOI : 10.1097/QAD.0b013e3283463ec5
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study, The Lancet, vol.370, issue.9585, pp.407-420, 2007. ,
DOI : 10.1016/S0140-6736(07)60948-9
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes, The Lancet, vol.364, issue.9428, pp.51-62, 2004. ,
DOI : 10.1016/S0140-6736(04)16589-6
Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort, AIDS Research and Therapy, vol.8, issue.1, 2011. ,
DOI : 10.1186/1742-6405-8-2
Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation, Nature Medicine, vol.41, issue.2, pp.208-222, 1998. ,
DOI : 10.1016/0022-1759(89)90260-3
CD4+ count-guided interruption of antiretroviral treatment, N Engl J Med, vol.355, pp.2283-96, 2006. ,
Magnitude and Determinants of CD4 Recovery After HAART Resumption After 1 Cycle of Treatment Interruption, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.52, issue.5, pp.588-94, 2009. ,
DOI : 10.1097/QAI.0b013e3181b9e94d
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection, PLoS Medicine, vol.180, issue.10, p.203, 2008. ,
DOI : 10.1371/journal.pmed.0050203.sd002
Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial, AIDS, vol.25, issue.9, pp.1207-1224, 2011. ,
DOI : 10.1097/QAD.0b013e3283471f10
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load, Blood, vol.104, issue.4, pp.942-949, 2004. ,
DOI : 10.1182/blood-2003-09-3333
Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression, AIDS, vol.24, issue.6, pp.819-850, 2010. ,
DOI : 10.1097/QAD.0b013e3283367836
Abacavir???Lamivudine versus Tenofovir???Emtricitabine for Initial HIV-1 Therapy, New England Journal of Medicine, vol.361, issue.23, pp.2230-2270, 2009. ,
DOI : 10.1056/NEJMoa0906768
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy, New England Journal of Medicine, vol.368, issue.3, pp.218-248, 2013. ,
DOI : 10.1056/NEJMoa1110187
Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant, New England Journal of Medicine, vol.369, issue.19, pp.1828-1863, 2013. ,
DOI : 10.1056/NEJMoa1302976